» Articles » PMID: 11908727

Survival of B Lineage Leukemic Cells: Signals from the Bone Marrow Microenvironment

Overview
Journal Leuk Lymphoma
Specialties Hematology
Oncology
Date 2002 Mar 23
PMID 11908727
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Stromal cells are an essential component of the bone marrow microenvironment that regulate development of immature hematopoietic progenitor cells. Through production of soluble cytokines, and signaling through adhesion molecule interactions, stromal cells impact survival, proliferation, and differentiation of hematopoietic progenitor cells. Similarities between normal pro-B and pre-B cells and B lineage acute lymphoblastic leukemic (ALL) progenitors have been well characterized which provide a model for investigation of the mechanisms by which ALL cells respond to bone marrow microenvironment signals. In addition to providing survival signals to B lineage ALL during initiation of disease, the bone marrow has long been recognized as a "sanctuary site" for leukemic cells during traditional chemotherapy. In the current review, mechanisms by which stromal cells contribute to leukemic cell survival, and the potential impact on treatment efficacy, are discussed. A growing appreciation of the significance of the bone marrow microenvironment in the progression of ALL, and further investigation of the signaling between leukemic progenitors and stromal cells, may contribute to novel treatment strategies aimed at enhancing sensitivity of ALL cells to currently available chemotherapeutic agents.

Citing Articles

Dynamic evolution of bone marrow adipocyte in B cell acute lymphoblastic leukemia: insights from diagnosis to post-chemotherapy.

Jia X, Liao N, Yao Y, Guo X, Chen K, Shi P Cancer Biol Ther. 2024; 25(1):2323765.

PMID: 38465622 PMC: 10936623. DOI: 10.1080/15384047.2024.2323765.


Physiologic IGFBP7 levels prolong IGF1R activation in acute lymphoblastic leukemia.

Artico L, Laranjeira A, Campos L, Correa J, Zenatti P, Carvalheira J Blood Adv. 2021; 5(18):3633-3646.

PMID: 34438446 PMC: 8945593. DOI: 10.1182/bloodadvances.2020003627.


Co-culture model of B-cell acute lymphoblastic leukemia recapitulates a transcription signature of chemotherapy-refractory minimal residual disease.

Rellick S, Hu G, Piktel D, Martin K, Geldenhuys W, Nair R Sci Rep. 2021; 11(1):15840.

PMID: 34349149 PMC: 8339057. DOI: 10.1038/s41598-021-95039-x.


Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity.

Zanetti S, Romecin P, Vinyoles M, Juan M, Fuster J, Camos M J Immunother Cancer. 2020; 8(2).

PMID: 32868394 PMC: 7462245. DOI: 10.1136/jitc-2020-001419.


Targeting the autophagy in bone marrow stromal cells overcomes resistance to vorinostat in chronic lymphocytic leukemia.

Ding L, Zhang W, Yang L, Pelicano H, Zhou K, Yin R Onco Targets Ther. 2018; 11:5151-5170.

PMID: 30210236 PMC: 6114474. DOI: 10.2147/OTT.S170392.